Report
Alex Morozov
EUR 147.86 For Business Accounts Only

Raising BD's FVE as We Upgrade Our Long-Term Growth Forecast; Shares Modestly Undervalued

We're raising our fair value estimate for Becton, Dickinson and Co to $186 per share, mainly due to our upgraded long-term growth forecast across most business lines. While some changes are minuscule (50-100 basis points), they have a significant impact on a company that recently saw growth in a 3%-4% range. Across the firm, we are seeing the effects of significant R&D investments, with BD's pipeline the strongest it's been in our history of covering the firm. The entire portfolio is expandi...
Underlying
Becton Dickinson and Company

Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The company's segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Alex Morozov

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch